Sort

Search

21/01/2025 Annexin A8 deficiency delays atherosclerosis progression
Gutiérrez-Muñoz, C, Blázquez-Serra, R, San Sebastian-Jaraba, I, Sanz-Andrea, S, Fernández-Gómez, MJ, Nuñez-Moreno, G, Mínguez, P, Escolá-Gil, JC, Nogales, P, Ollivier, V, Martín-Ventura, JL, Noe, BHT, Rescher, U, Méndez-Barbero, N, Blanco-Colio, LM. Annexin A8 deficiency delays atherosclerosis progression. Clinical and Translational Medicine. 2025; 15(1)DOI:10.1002/ctm2.70176. PMID:39835780. IF:6.800(Q1/2D).
21/01/2025 Real-World Experience in Tricuspid Transcatheter Edge-to-Edge Repair: Transcatheter Tricuspid Valve Repair in Spain Registry
Sisinni, A, Barreiro-Perez, M, Freixa, X, Arzamendi, D, Moñivas, V, Carrasco-Chinchilla, F, Pan, M, Nombela-Franco, L, Pascual, I, Benito-González, T, Perez, R, Gómez-Blázquez, I, Amat-Santos, IJ, Cruz-González, I, Sánchez-Recalde, A, Alvarez, ABC, Sanchis, L, Caneiro-Queija, B, Li, CH, del Trigo, M, Martínez-Carmona, JD, Mesa, D, Pozo, E, Avanzas, P, Cepas-Guillén, P, Estévez-Loureiro, R. Real-World Experience in Tricuspid Transcatheter Edge-to-Edge Repair: Transcatheter Tricuspid Valve Repair in Spain Registry. Journal of the American Heart Association. 2025; 14(2)DOI:10.1161/JAHA.124.037070. PMID:39818971. IF:5.300(Q1/2D).
20/01/2025 Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab as the Upfront Treatment in Patients With Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS)
Martin-Broto, J, Diaz-Beveridge, R, Moura, D, Ramos, R, Martinez-Trufero, J, Carrasco, I, Sebio, A, Gonzalez-Billalabeitia, E, Gutierrez, A, Fernandez-Jara, J, Hernandez-Vargas, L, Cruz, J, Valverde, C, Hindi, N. Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab as the Upfront Treatment in Patients With Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS). JOURNAL OF CLINICAL ONCOLOGY. 2025; 43(3)DOI:10.1200/JCO.24.00358. PMID:39356980. IF:41.900(Q1/1D).
20/01/2025 Economic evaluation of a strategy to shorten the time to surgery with neuraxial anaesthesia compared with usual clinical practice in patients on chronic antiplatelet therapy with a proximal femur fracture
Delgado-Espinoza, CE, Antonijoan, RM, Gich, I, Anaya, R, Rodriguez, M, Millan, A, Llorca, J, Usua, G, Ruiz, A, Merchán-Galvis, A, Martinez-Zapata, MJ. Economic evaluation of a strategy to shorten the time to surgery with neuraxial anaesthesia compared with usual clinical practice in patients on chronic antiplatelet therapy with a proximal femur fracture. Frontiers In Health Services. 2025; 4DOI:10.3389/frhs.2024.1423975. PMID:39901976. IF:(Q/D).
18/01/2025 Comparison of the amyloid plaque proteome in Down syndrome, early-onset Alzheimer's disease, and late-onset Alzheimer's disease
Martá-Ariza, M, Leitner, DF, Kanshin, E, Suazo, J, Pedrosa, AG, Thierry, M, Lee, EB, Devinsky, O, Drummond, E, Fortea, J, Lleó, A, Ueberheide, B, Wisniewski, T. Comparison of the amyloid plaque proteome in Down syndrome, early-onset Alzheimer's disease, and late-onset Alzheimer's disease. ACTA NEUROPATHOLOGICA. 2025; 149(1)DOI:10.1007/s00401-025-02844-z. PMID:39825890. IF:9.300(Q1/1D).
18/01/2025 Oxytocin levels in response to CRH administration in hypopituitarism and hypothalamic damage: a randomized, crossover, placebo-controlled trial
Asla, Q, Garrido, M, Urgell, E, Terzan, S, Santos, A, Fernández, M, Varghese, N, Atila, C, Calabrese, A, Biagetti, B, Plessow, F, Gich, I, Christ-Crain, M, Eckert, A, Webb, SM, Lawson, EA, Aulinas, A. Oxytocin levels in response to CRH administration in hypopituitarism and hypothalamic damage: a randomized, crossover, placebo-controlled trial. Scientific Reports. 2025; 15(1)DOI:10.1038/s41598-025-86566-y. PMID:39824923. IF:3.900(Q1/2D).
17/01/2025 Aging towards walkable futures: insights from a multidisciplinary workshop held in Barcelona, Spain
Vall-Garcia, E, Delgado-Ortiz, L, Alcock, L, Coll-Planas, L, García-Navarro, JA, Iwarsson, S, Jansà, JM, Jansen, CP, Koch, S, Schwartz, S, Rantakokko, M, Sarukhan, A, van Staalduinen, W, Rochester, L, Garcia-Aymerich, J. Aging towards walkable futures: insights from a multidisciplinary workshop held in Barcelona, Spain. BMC PUBLIC HEALTH. 2025; 25(1)DOI:10.1186/s12889-024-21223-z. PMID:39825288. IF:3.600(Q1/2D).
16/01/2025 A new STI in the city: MPOX in Barcelona. First outbreak (5/2022-5/2023) and subsequent resurgence
Palma, D, Guillaumes, M, Pericas, C, de Andrés, A, Prieto, R, Alvarez-Bruned, L, Ospina, J, Santiá, P, García de Olalla, P, Rius, C. A new STI in the city: MPOX in Barcelona. First outbreak (5/2022-5/2023) and subsequent resurgence. PLoS One. 2025; 20(1)DOI:10.1371/journal.pone.0296141. PMID:39821125. IF:2.600(Q2/4D).
16/01/2025 A multicenter study of perioperative and functional outcomes of open vs. robot assisted uretero-enteric reimplantation after radical cystectomy
Ajami, T, Musquera, M, Palou, J, Guru, KA, Hussein, AA, Eun, D, Hosseini, A, Gaya, JM, Abaza, R, Iqbal, U, Lee, R, Lee, ZH, Lee, M, Raventos, C, Breda, A, Lozano, F, Trilla, E, Vigués, F, Carrion, A. A multicenter study of perioperative and functional outcomes of open vs. robot assisted uretero-enteric reimplantation after radical cystectomy. WORLD JOURNAL OF UROLOGY. 2025; 43(1)DOI:10.1007/s00345-024-05435-x. PMID:39820547. IF:2.900(Q2/3D).
16/01/2025 A Homozygous ATP2A2 Variant Alters Sarcoendoplasmic Reticulum Ca2+-ATPase 2 Function in Skeletal Muscle and Causes a Novel Vacuolar Myopathy
Llansó, L, Ravenscroft, G, Aceituno, C, Gutiérrez, A, Parmar, J, Gallano, P, Caballero-avila, M, Carbayo, A, Vesperinas, A, Collet, R, Blanco, R, Laing, N, Hove-Madsen, L, Gallardo, E, Olivé, M. A Homozygous ATP2A2 Variant Alters Sarcoendoplasmic Reticulum Ca2+-ATPase 2 Function in Skeletal Muscle and Causes a Novel Vacuolar Myopathy. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2025; 51(1)DOI:10.1111/nan.70000. PMID:39817497. IF:3.400(Q1/3D).
15/01/2025 Clinical and imaging spectrum of non-congenital dominant ACTN2 myopathy
Iruzubieta, P, Verdú-Díaz, J, Töpf, A, Luce, L, Claeys, KG, De Ridder, W, González-Quereda, L, de la Hoz, CPD, Poza, JJ, Zulaica, M, de Jonghe, P, Duff, J, Mroczek, M, Martín-Jiménez, P, Hernández-Laín, A, Domínguez-González, C, Baets, J, Gallano, P, Díaz-Manera, J, Straub, V, de Munain, AL, Fernandez-Torron, R. Clinical and imaging spectrum of non-congenital dominant ACTN2 myopathy. JOURNAL OF NEUROLOGY. 2025; 272(2)DOI:10.1007/s00415-025-12893-9. PMID:39812845. IF:4.600(Q1/2D).
15/01/2025 Impact of mechanical circulatory support on outcomes in Takotsubo syndrome complicated by cardiogenic shock: Insights from the RETAKO registry
Uribarri, A, Vazirani, R, Delia, MA, Tomasino, M, Fernández-Cordón, C, Martín, A, Blanco-Ponce, E, Salamanca, J, Corbí-Pascual, M, Vedia, O, Duran-Cambra, A, Becerra-Muñoz, VM, Lluch-Requerey, C, Raposeiras-Roubin, S, Guillén-Marzo, M, Lopez-País, J, Pérez-Castellanos, A, Mayordomo, PS, Martínez-Sellés, M, Vila-Sanjuán, S, Ródenas-Alesina, E, Núñez-Gil, IJ. Impact of mechanical circulatory support on outcomes in Takotsubo syndrome complicated by cardiogenic shock: Insights from the RETAKO registry. INTERNATIONAL JOURNAL OF CARDIOLOGY. 2025; 419DOI:10.1016/j.ijcard.2024.132681. PMID:39454688. IF:3.200(Q2/3D).
15/01/2025 Urban yellow-legged gull (Larus michahellis) and peri-urban Audouin's gull (Larus audouinii) as a source of Campylobacter and Salmonella of public health relevance.
Manzanares-Pedrosa A, Ayats T, Antilles N, Sabaté S, Planell R, González R, Montalvo T, Cerdà-Cuéllar M. Urban yellow-legged gull (Larus michahellis) and peri-urban Audouin's gull (Larus audouinii) as a source of Campylobacter and Salmonella of public health relevance.. The Science of the total environment. 2025; 960DOI:10.1016/j.scitotenv.2024.178227. PMID:39765169. IF:(Q/D).
15/01/2025 A French multicenter analytical evaluation of the automated Lumipulse G sNfL blood assay (Fujirebio®) and its comparison to four other immunoassays for serum neurofilament light chain assessment in clinical settings
Mondésert, E, Schraen-Maschke, S, Quadrio, I, Bousiges, O, Bouvier, D, Delaby, C, Bedel, A, Lehmann, S, Fourier, A. A French multicenter analytical evaluation of the automated Lumipulse G sNfL blood assay (Fujirebio®) and its comparison to four other immunoassays for serum neurofilament light chain assessment in clinical settings. CLINICA CHIMICA ACTA. 2025; 565DOI:10.1016/j.cca.2024.120007. PMID:39454987. IF:2.900(Q1/1D).
14/01/2025 Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome
Rodríguez-Baz, I, Benejam, B, Morcillo-Nieto, AO, Vaqué-Alcázar, L, Arriola-Infante, JE, Camacho, V, Aranha, MR, Carmona-Iragui, M, Videla, L, Barroeta, I, Fernández, S, Zsadanyi, SE, Giménez, S, Arranz, J, Blesa, LM, Alcolea, D, Lleó, A, Bejanin, A, Fortea, J. Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome. NEUROLOGY. 2025; 104(1)DOI:10.1212/WNL.0000000000210179. PMID:39689339. IF:8.500(Q1/1D).
11/01/2025 Do Unresectable Giant Cell Tumors of Bone Treated With Denosumab Progress After Discontinuation of Treatment?
de la Calva, C, Angulo, M, González-Rojo, P, Peiró, A, Machado, P, Cebrián, JL, García-Maroto, R, Valcárcel, A, Puertas, P, Valero-Cifuentes, G, Pablos, O, Maireles, M, Fontalva, ML, Chaves, I, Orce, A, Coll-Mesa, L, Pérez, I, González, F, Sanz, MD, Gracia, I. Do Unresectable Giant Cell Tumors of Bone Treated With Denosumab Progress After Discontinuation of Treatment?. Cancer Reports. 2025; 8(1)DOI:10.1002/cnr2.70117. PMID:39797695. IF:(Q/D).
11/01/2025 Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group
Oñate, G, Garrido, A, Arnan, M, Pomares, H, Alonso, E, Tormo, M, Diaz-Beya, M, Vives, S, Zamora, L, Sampol, A, Coll, R, Salamero, O, Cervera, M, Garcia, A, Vall-Llovera, F, Garcia-Avila, S, Bargay, J, Ortin, X, Iranzo, E, Guijarro, F, Pratcorona, M, Nomdedeu, JF, Esteve, J, Sierra, J. Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group. Blood Cancer Journal. 2025; 15(1)DOI:10.1038/s41408-024-01205-5. PMID:39799145. IF:11.600(Q1/1D).
10/01/2025 Variations and Opportunities in Postnatal Management of Hemolytic Disease of the Fetus and Newborn
de Winter, DP, Verweij, EJT, Debeer, A, Devlieger, R, Lewi, L, Verbeeck, S, Maurice, P, Jouannic, JM, Guillemin, MG, Mailloux, A, dos Santos, MCP, Pacheco, CADS, Moreira, MEL, Vaena, MMD, Bohlin, K, Tiblad, E, Thorup, E, Petersen, OB, Sanchez-Holgado, M, Llorente, AV, Poljak, B, Khalil, A, Le Duc, K, Ghesquiere, L, Krivec, JL, Soltirovska-Salamon, A, Dame, C, Blank, JD, Hohnecker, A, Saxonhouse, M, Connors, NK, Geipel, A, Rath, J, Prasad, S, van Wyk, L, Geerts, L, Schuler, R, Thon, N, Leibovitch, L, Cohen, S, Canul-Euan, AA, Kelly, E, Raghuram, K, Cavigioli, F, Colombo, SFG, Elanjikal, Z, Brayley, J, Pfurtscheller, D, Pichler, G, Grisi, AGA, Navarro, EJJC, Pereira-Nunes, J, Soares, H, Zhou, M, Borau, MJG, Calderon, EM, Galletti, MF, Mariani, GL, Mackin, D, Malone, F, Lampland, A, Tse, WT, Castleman, J, van der Bom, JG, de Haas, M, Lopriore, E, Fetus Newborn DIONYSUS Investigators. Variations and Opportunities in Postnatal Management of Hemolytic Disease of the Fetus and Newborn. JAMA Network Open. 2025; 8(1)DOI:10.1001/jamanetworkopen.2024.54330. PMID:39792381. IF:9.700(Q1/1D).
09/01/2025 Raising awareness and addressing inequities for people with Down syndrome in South Africa
Mcglinchey, E, Fortea, J, Vava, B, Andrews, Y, Ranchod, K, Kleinhans, A. Raising awareness and addressing inequities for people with Down syndrome in South Africa. International Journal for Equity in Health. 2025; 24(1)DOI:10.1186/s12939-024-02349-3. PMID:39789562. IF:4.100(Q1/2D).
07/01/2025 Clinical management of female patients with Fabry disease based on expert consensus
Brand, E, Linhart, A, Deegan, P, Jurcut, R, Pisani, A, Torra, R, Feldt-Rasmussen, U. Clinical management of female patients with Fabry disease based on expert consensus. Orphanet Journal of Rare Diseases. 2025; 20(1)DOI:10.1186/s13023-024-03500-7. PMID:39773286. IF:3.500(Q2/4D).